Junto Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-234,003
Closed -$23.7M 88
2025
Q1
$23.7M Sell
234,003
-182,599
-44% -$17.8M 0.5% 70
2024
Q4
$38.5M Sell
416,602
-531,841
-56% -$52.2M 0.74% 51
2024
Q3
$91.7M Buy
948,443
+99,526
+12% +$8.94M 2.03% 13
2024
Q2
$72.8M Buy
848,917
+120,436
+17% +$10.1M 1.49% 22
2024
Q1
$60.2M Sell
728,481
-216,669
-23% -$15.9M 1.33% 32
2023
Q4
$63.1M Buy
945,150
+271,477
+40% +$17.6M 1.41% 28
2023
Q3
$45.2M Sell
673,673
-24,824
-4% -$1.71M 1.07% 40
2023
Q2
$47.3M Buy
+698,497
New +$43.8M 1.2% 35
2023
Q1
Sell
-656,480
Closed -$39.3M 93
2022
Q4
$39.3M Buy
+656,480
New +$35.7M 1.11% 39

Other funds holding EHC

Junto Capital Management's EHC Position: Q2 2025 in Review

Junto Capital Management sold out of Encompass Health (EHC) in Q2 2025, closing a stake of 234,003 shares — an estimated $23.7M sold.

Junto Capital Management first reported a position in EHC in Q4 2022 and held it in 9 quarters. The position peaked at $91.7M in Q3 2024. 607 funds tracked by Wall St. Rank hold EHC as of Q2 2025.

  • Junto Capital Management reported no remaining Encompass Health position as of Q2 2025 after selling out during the quarter.
  • Junto Capital Management sold 234,003 Encompass Health shares in Q2 2025, an estimated $23.7M.
  • Junto Capital Management first reported a position in Encompass Health in Q4 2022 and held it in 9 quarters.
  • Junto Capital Management's Encompass Health position peaked at $91.7M in Q3 2024.
  • 607 funds tracked by Wall St. Rank held Encompass Health as of Q2 2025.

Based on Junto Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.